Skip to content
HeyJared

David Prosser

Reporter

Indexed articles, last 90 days
2
Latest publication
Jul 10, 2026
Outlet visibility, for MoneyWeek
Top 500K sites
Earliest in this view
Jul 5, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 10, 2026 · David Prosser

    The future looks bright for biotechnology companies – investments to buy (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Good news for shareholders in the International Biotechnology Trust: their fund has a significant holding in US cancer research business Nuvalent, for which GSK has just agreed to pay $10.6 billion– 40% more than its share price prior to the deal being announced. Even better: Nuvalent is the sixth company in the portfolio to have been acquired at a premium this year. The deals are part of a spree of merger and acquisition (M&A) activity taking place in the global biotechnology sector – to the be

  2. Article · Jul 5, 2026 · David Prosser

    How asset finance can help your company grow (opens the original)

    Excerpt

    Read excerpt

    Asset finance can make more sense than a bank loan for a small business – but seek advice before signing on, says David Prosser

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For MoneyWeek, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about David Prosser